Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085183887> ?p ?o ?g. }
- W2085183887 endingPage "e26218" @default.
- W2085183887 startingPage "e26218" @default.
- W2085183887 abstract "We evaluated a neutralizing anti-TGFβ antibody (GC1008) in cancer patients with malignant pleura mesothelioma (MPM). The goal of this study was to assess immunoregulatory effects in relation to clinical safety and clinical response. Patients with progressive MPM and 1-2 prior systemic therapies received GC1008 at 3mg/kg IV over 90 min every 21 d as part of an open-label, two-center Phase II trial. Following TGFβ blockade therapy, clinical safety and patient survival were monitored along with the effects of anti-TGFβ antibodies on serum biomarkers and peripheral blood mononuclear cells (PBMC). Although designed as a larger trial, only 13 patients were enrolled when the manufacturer discontinued further development of the antibody for oncology indications. All participants tolerated therapy. Although partial or complete radiographic responses were not observed, three patients showed stable disease at 3 mo. GC1008 had no effect in the expression of NK, CD4+, or CD8+ T cell activating and inhibitory markers, other than a decrease in the expression of 2B4 and DNAM-1 on NK cells. However, serum from 5 patients showed new or enhanced levels of antibodies against MPM tumor lysates as measured by immunoblotting. Patients who produced anti-tumor antibodies had increased median overall survival (OS) (15 vs 7.5 mo, p < 0.03) compared with those who did not. To our knowledge, these data represent the first immune analysis of TGFβ- blockade in human cancer patients." @default.
- W2085183887 created "2016-06-24" @default.
- W2085183887 creator A5005953721 @default.
- W2085183887 creator A5005961410 @default.
- W2085183887 creator A5016068947 @default.
- W2085183887 creator A5026614969 @default.
- W2085183887 creator A5039385026 @default.
- W2085183887 creator A5056234830 @default.
- W2085183887 creator A5057398938 @default.
- W2085183887 creator A5069209710 @default.
- W2085183887 creator A5070821158 @default.
- W2085183887 creator A5077422513 @default.
- W2085183887 creator A5079376334 @default.
- W2085183887 creator A5088906229 @default.
- W2085183887 creator A5090156519 @default.
- W2085183887 creator A5090256464 @default.
- W2085183887 date "2013-08-01" @default.
- W2085183887 modified "2023-10-14" @default.
- W2085183887 title "Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients" @default.
- W2085183887 cites W1565561072 @default.
- W2085183887 cites W1571796034 @default.
- W2085183887 cites W1964945438 @default.
- W2085183887 cites W1974252673 @default.
- W2085183887 cites W1977062776 @default.
- W2085183887 cites W1980487981 @default.
- W2085183887 cites W1981040379 @default.
- W2085183887 cites W1983928963 @default.
- W2085183887 cites W1992909341 @default.
- W2085183887 cites W2007510256 @default.
- W2085183887 cites W2010632863 @default.
- W2085183887 cites W2012492706 @default.
- W2085183887 cites W2020914260 @default.
- W2085183887 cites W2021896163 @default.
- W2085183887 cites W2023961961 @default.
- W2085183887 cites W2026460094 @default.
- W2085183887 cites W2030259772 @default.
- W2085183887 cites W2041288370 @default.
- W2085183887 cites W2043176282 @default.
- W2085183887 cites W2045598455 @default.
- W2085183887 cites W2048171393 @default.
- W2085183887 cites W2048517100 @default.
- W2085183887 cites W2064826198 @default.
- W2085183887 cites W2068264084 @default.
- W2085183887 cites W2069945021 @default.
- W2085183887 cites W2072255058 @default.
- W2085183887 cites W2074133524 @default.
- W2085183887 cites W2078985610 @default.
- W2085183887 cites W2093488156 @default.
- W2085183887 cites W2094586578 @default.
- W2085183887 cites W2100158834 @default.
- W2085183887 cites W2100576484 @default.
- W2085183887 cites W2112988722 @default.
- W2085183887 cites W2117114306 @default.
- W2085183887 cites W2118447882 @default.
- W2085183887 cites W2119236548 @default.
- W2085183887 cites W2120010406 @default.
- W2085183887 cites W2121158936 @default.
- W2085183887 cites W2122411707 @default.
- W2085183887 cites W2129026847 @default.
- W2085183887 cites W2130276477 @default.
- W2085183887 cites W2130643308 @default.
- W2085183887 cites W2134013248 @default.
- W2085183887 cites W2136280424 @default.
- W2085183887 cites W2143015936 @default.
- W2085183887 cites W2146995890 @default.
- W2085183887 cites W2150319141 @default.
- W2085183887 cites W2150548551 @default.
- W2085183887 cites W2153060237 @default.
- W2085183887 cites W2158393791 @default.
- W2085183887 cites W2161112755 @default.
- W2085183887 cites W2165608627 @default.
- W2085183887 cites W2168841084 @default.
- W2085183887 doi "https://doi.org/10.4161/onci.26218" @default.
- W2085183887 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3812201" @default.
- W2085183887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24179709" @default.
- W2085183887 hasPublicationYear "2013" @default.
- W2085183887 type Work @default.
- W2085183887 sameAs 2085183887 @default.
- W2085183887 citedByCount "69" @default.
- W2085183887 countsByYear W20851838872014 @default.
- W2085183887 countsByYear W20851838872015 @default.
- W2085183887 countsByYear W20851838872016 @default.
- W2085183887 countsByYear W20851838872017 @default.
- W2085183887 countsByYear W20851838872018 @default.
- W2085183887 countsByYear W20851838872019 @default.
- W2085183887 countsByYear W20851838872020 @default.
- W2085183887 countsByYear W20851838872021 @default.
- W2085183887 countsByYear W20851838872022 @default.
- W2085183887 countsByYear W20851838872023 @default.
- W2085183887 crossrefType "journal-article" @default.
- W2085183887 hasAuthorship W2085183887A5005953721 @default.
- W2085183887 hasAuthorship W2085183887A5005961410 @default.
- W2085183887 hasAuthorship W2085183887A5016068947 @default.
- W2085183887 hasAuthorship W2085183887A5026614969 @default.
- W2085183887 hasAuthorship W2085183887A5039385026 @default.
- W2085183887 hasAuthorship W2085183887A5056234830 @default.
- W2085183887 hasAuthorship W2085183887A5057398938 @default.
- W2085183887 hasAuthorship W2085183887A5069209710 @default.